4
Changes in Ownership
Unicycive Therapeutics, Inc. Filed Acc 0001213900-25-080808
Director acquired 652,900 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Aggarwal Gaurav · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-08-25 | Conversion : show line 1 in the form | +652,900 | 1,789,915 | I |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-25 | Returned to the company : show line 2 in the form Series A-2 Prime Preferred Stock | −3,199.21 | $1,000.00 | $3,199,210 | 0 | I |
Loading xslF345X05/ownership.xml…